Comerica Bank
BBC icon

Comerica Bank’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Comerica Bank’s Portfolio BBC Stock Details BBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35
Closed -$884 – 3679
2024
Q2 		$884 Sell
35
-248
-88% -$6.62K ﹤0.01% 3593
2024
Q1 		$8.24K Buy
+283
New +$7.76K ﹤0.01% 3223

Other funds holding BBC

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
DWS
Dynamic Wealth Strategies Granite Bay, California $188M AUM 18.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Comerica Bank's BBC Position: Q3 2024 in Review

Comerica Bank sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q3 2024, closing a stake of 35 shares — an estimated $884 sold.

Comerica Bank first reported a position in BBC in Q1 2024 and held it in 2 quarters. The position peaked at $8.24K in Q1 2024. 13 funds tracked by Wall St. Rank hold BBC as of Q3 2024.

  • Comerica Bank reported no remaining Virtus Biotech Clinical Trials ETF position as of Q3 2024 after selling out during the quarter.
  • Comerica Bank sold 35 Virtus Biotech Clinical Trials ETF shares in Q3 2024, an estimated $884.
  • Comerica Bank first reported a position in Virtus Biotech Clinical Trials ETF in Q1 2024 and held it in 2 quarters.
  • Comerica Bank's Virtus Biotech Clinical Trials ETF position peaked at $8.24K in Q1 2024.
  • 13 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2024.

Based on Comerica Bank's 13F filing for Q3 2024, filed 14 Nov 2024.